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In this study, we investigated the autoimmune response in rabbit ovaries following infection with a recombinant myxoma virus expressing
rabbit zona pellucida protein B (MV-ZPB). A specific IgG antibody response to ZPB was elicited in the serum of infected rabbits and the
antibody strongly bound to the zona pellucida of oocytes in secondary and tertiary follicles. T cell infiltration in the ovary was detected in a
small proportion of the infected rabbits. In spite of this, the mean number of preovulatory and tertiary follicles in the ovary was significantly
reduced at 30 days postinfection compared with that of the infected and uninfected controls. Histological analysis revealed that the cortex and
medulla of these ovaries had accumulated a large number of probably luteinized cells and there were no follicles in these areas, indicating the
ovaries were in a severe pathological condition. The data suggest that the delivery of ZP antigens using a recombinant myxoma virus is a
prospective way to develop immunocontraceptive vaccines for rabbit population control, but that more understanding of the kinetics of the
autoimmune response induced by viral delivery is needed.
D 2003 Elsevier Inc. All rights reserved.Keywords: Recombinant myxoma virus; Rabbit ZPB; Ovary; ImmunocontraceptionIntroduction
The European rabbit (Oryctolagus cuniculus) is an in-
troduced vertebrate pest species in Australia, causing sig-
nificant losses in agricultural production and severe
environmental degradation on a continent-wide scale (Hol-
land and Jackson, 1994). Reduction of rabbit population
through fertility control could add to the currently used
lethal-based methods such as trapping, poisoning, shooting,
and introduction of viral disease. Therefore, Tyndale-Biscoe
(1994) proposed developing an immunocontraceptive vac-
cine delivered by a recombinant myxoma virus as a self-
disseminating vector. Myxoma virus is a poxvirus (genus:
Leporipoxvirus) that causes the lethal disease myxomatosis
in the European rabbit. The virus was released in Australia
in 1950 as a biological control agent and is now endemic in
the Australian rabbit population (Fenner and Fantini, 1999).0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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nocontraceptive antigen is important. Our previous study
has shown that infection of female rabbits with a recombi-
nant myxoma virus encoding a model antigen HA can
induce a strong systemic IgG antibody response to HA,
and that the antibody can fully access the ovary but not the
reproductive tract (Gu et al., 2003). This suggested that
targeting ovarian antigens may have more chance of being
successful in developing an immunocontraceptive than
targeting antigens within the reproductive tract. In this
paper, we tested whether recombinant myxoma virus could
deliver an ovarian zona pellucida (ZP) antigen and induce
an autoimmune response in the ovary.
ZP is an extracellular matrix surrounding the oocytes
which plays an important role in oocyte development and
fertilization (Epifano and Dean, 1994). Porcine ZP has been
used as a common ovarian antigen for immunocontraception
(Paterson et al., 2000; Skinner et al., 1996).
Like most other species, the rabbit ZP consists of three
major glycoproteins ZPA, ZPB, ZPC with predicted molec-
ular weights of about 75, 55, and 45 kDa, respectively
(Dunbar et al., 1994). ZPB was shown to be the rabbit
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sperm binding in this species (Dunbar et al., 1994) and it
therefore may have the potential to be an immunocontra-
ceptive antigen.
Female rabbits are normally immunologically tolerant to
immunization with either rabbit native ZP protein (Skinner
et al., 1987; Wood et al., 1981) or recombinant ZPB
expressed in bacteria (Prasad et al., 1995). However, rabbit
ZPB expressed in a eukaryotic expression system showed an
enhanced immunogenicity (Prasad et al., 1995) although no
fertility results were reported. Immunization of female
rabbits with rabbit ZPB expressed in a rabbit cell line
resulted in 75% infertility (Kerr et al., 1999). These data
indicate that posttranslation processes such as glycosylation
of ZPB protein in eukaryotic cells are an important deter-
minant in affecting the immunogenicity of ZP protein. More
importantly, it was shown that rabbit ZPB encoded by a
recombinant myxoma virus could overcome self-tolerance
and induce an antibody response in female rabbits (Kerr et
al., 1999).
To understand the mechanism of autoimmune infertility
induced by a recombinant myxoma virus and provide a
basis for further development of an effective viral vectored
immunocontraceptive vaccine, we used a recombinant myx-
oma virus expressing rabbit zona pellucida protein B (MV-
ZPB) to investigate the immunological and histological
responses in the ovary in a time course after infection.
Our study also aimed to explore the roles of antibody and T
cell response in ovarian pathogenesis.Fig. 1. IgG antibody reaction to ZP in the ovary after MV-ZPB infection. A
and B are ovaries from the MV-ZPB Day 30 group showing the IgG
antibody strongly binding to ZPs of oocytes in the secondary (A, arrows)
and tertiary follicles (B, arrow). C is also an ovary from the same group
above but consists of two parts; the left is a phase contrast image showing
the structure of ZP (arrow) and follicle, and the right is the corresponding
immunofluorescent image showing that the fluorescence is only on ZP
(arrow). D is an ovary from the MV-HA D15 group showing that there is no
or only a very weak IgG antibody binding (arrow) in the follicle (Fo). All
images are at the same magnification.Results
Antibody response in serum and in the ovary
Groups of four rabbits infected with MV-ZPB were killed
at 5, 15, and 30 days after infection. Control rabbits infected
with MV-HA were killed at days 15 and 30. Inflammatory
reactions at the inoculation sites were observed at 6 days
postinfection with MV-ZPB. All infected rabbits experi-
enced mild myxomatosis and developed secondary myxo-
mas on ears, eyelids, or noses around 15 days postinfection.
About day 20 postinfection, these rabbits started to recover,
and by day 30 postinfection, all had recovered from myx-
omatosis. No secondary myxomas were observed in rabbits
infected with MV-HA.
Serum IgG antibody to ZPB was detected in two rabbits
in the MV-ZPB Day 5 group with Log10 titers of 1.7 and
1.4. The antibody titer peaked at 15 days after infection with
a mean antibody titer of 3.2 F 0.5 (mean Log10 titer F SD)
and then dropped to 2.3 F 0.3 at 30 days postinfection. ZPB
IgG was not detected in preimmune serum from those
rabbits and in serum from MV-HA-infected or -uninfected
control rabbits.
To detect ZPB antibody binding to oocytes in the ovary,
we labelled rabbit IgG in frozen ovarian sections from allgroups using indirect immunofluorescence. Strong IgG
staining on ZP of oocytes was found in ovaries from the
MV-ZPB Day 15 and Day 30 groups (Fig. 1). However,
such staining was not found in ovaries from the MV-ZPB
Day 5 group and MV-HA-infected rabbits, though a very
weak staining could occasionally be found in a follicle (Fig.
1). Similarly, no IgG staining was seen in follicles from
ovaries of uninfected controls. These results indicate that the
ZPB antibody induced by MV-ZPB infection has entered the
ovary and bound to the ZP of the oocytes.
IgG antibody binds to ZP protein in vitro
To confirm the specificity of serum IgG antibody, we
conducted Western blotting using mixed serum from MV-
ZPB-infected rabbits as the first antibody. One specific
protein band at a molecular weight about 70 kDa was
recognized on the lane loaded with native ZP protein
whereas no protein band was recognized on the lane loaded
with unrelated proteins (Fig. 2). This recognized ZP protein
is in the MW range of native rabbit ZPB reported previously
(Dunbar et al., 1981).
To further confirm that serum IgG antibody was binding
to the ZP protein, we carried out an in vitro immunofluo-
rescence assay and used the mixed serum from MV-ZPB-
infected rabbits as the primary antibody to bind to ZP in
frozen ovarian sections from uninfected controls or the MV-
ZPB Day 5 group. This serum bound to most ZPs in
secondary and tertiary follicles (Fig. 2). Mixed serum from
MV-HA-infected rabbits was used as controls, but there was
no antibody binding (Fig. 2). These results show that the
ZPB IgG antibody in serum of MV-ZPB-infected rabbits can
specifically bind to ZPB in vitro.
Fig. 3. CD43+ and KEN-5+ cells in the ovary of MV-ZPB-infected rabbits.
A and B are ovaries from the MV-ZPB Day 5 and 15 groups and represent
most of the infected rabbits showing that CD43+ (A) and KEN-5+ (B) cells
are not commonly seen in the ovary. C and D are serial ovarian sections
from one of four rabbits with T cell infiltration in MV-ZPB Day 5 group
showing the infiltrated CD43+ (C) and KEN-5+ (D) cells in the ovary.
Similar numbers of CD43+ and KEN-5+ cells were present in the ovary and
most of the cells were located closely around the follicle (Fo). All images
are of the same magnification.
Table 1
Fresh ovarian weight and preovulatory follicles from infected and
uninfected rabbits
Groups Left ovary (g) Right ovary (g) Preovulatory
follicles
Controls 0.32 F 0.04 0.33 F 0.04 6.5 F 1.7
MV-ZPB Day 5 0.22 F 0.05* 0.25 F 0.06 5.0 F 2.2
MV-ZPB Day 15 0.15 F 0.05** 0.13 F 0.06** 4.3 F 1.9
MV-HA Day 15 0.16 F 0.07** 0.16 F 0.06** 4.3 F 1.3
MV-ZPB Day 30 0.19 F 0.05** 0.19 F 0.07* 2.3 F 1.5y
MV-HA Day 30 0.13 F 0.03** 0.14 F 0.02** 5.8 F 1.3
Notes: the values are mean F SD for four rabbits in each group.
*P < 0.05 against uninfected controls.
**P < 0.01 against uninfected controls.
y P < 0.05 against infected (MV-HA Day 30) and uninfected controls.
Fig. 2. Serum IgG antibody binding to ZP in vitro. A shows Western blot.
Lane 1: protein marker, lane 2: BSA, and lane 3: rabbit whole ZP. B shows
that IgG antibody in mixed serum from MV-ZPB-infected rabbits can bind
to ZP in the secondary (B, arrow) follicle in vitro. C represents the ovary
treated with mixed serum from MV-HA-infected rabbits and there is no
antibody binding. Images B and C are of the same magnification.
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To examine T cell responses or inflammatory reactions
in the ovary, we stained rabbit T cells in frozen ovarian
sections using two monoclonal antibodies, clone KEN-5
and L11/135. KEN-5 was previously reported to recognize
rabbit T cells (Kotani et al., 1993) with an undefined T cell
marker (Mage, 1998) while L11/135 recognizes an antigen
equivalent to human leukosialin/CD43 with a restricted
reaction to T cells (Jackson et al., 1983; Wilkinson et al.,
1992). KEN-5+ cells were not commonly seen and CD43+
T cells were also present in only small numbers in the
ovary of the uninfected controls. However, after MV-ZPB
infection, significant infiltrations of KEN-5+ and CD43+
cells were found in the ovary from one rabbit in the day 5
group and one rabbit in the day 15 group (Fig. 3). In these
cases, many positive cells were present in the ovarian
cortex with most of them located closely around the
follicles (Fig. 3). Other rabbits in these two groups and
rabbits in the MV-ZPB Day 30 group were not different
from uninfected controls (Fig. 3). For MV-HA-infected
rabbits, compared with the uninfected controls, more KEN-
5+ cells were present in one rabbit in the MV-HA Day 30
group and more CD43+ cells were seen in two rabbits in
the MV-HA Day 15 group. In these cases, the positive
cells were also located around the follicles, but the cell
numbers were much lower than those in the two rabbits in
the MV-ZPB Day 5 and Day 15 groups. The other rabbits
in the MV-HA Day 15 and Day 30 groups were similar to
those in uninfected controls.
Ovarian pathology
Ovarian weights were recorded when they were collected
for histological analysis (Table 1). The mean ovarian weightfor both MV-ZPB- and MV-HA-infected groups at either 15
or 30 days postinfection was significantly lower than that of
the uninfected group (Table 1). But there were no differ-
ences in the mean ovarian weight between MV-ZPB- and
MV-HA-infected rabbits at either time point. In the MV-
ZPB Day 5 group, only the left ovary weight was signifi-
cantly lower than that of uninfected controls.
Four to six longitudinal sections were cut from each
ovary and stained with H&E. Fewer follicles were seen on
sections from the MV-ZPB-infected group than those from
uninfected and MV-HA-infected controls (Fig. 4). The
preovulatory follicles (>0.5 mm in diameter) were counted
(Table 1). Compared with the uninfected controls and the
MV-HA Day 30 group, the MV-ZPB Day 30 group had
significantly fewer preovulatory follicles (Table 1). Histo-
logically, reduced numbers of tertiary and secondary fol-
licles were also observed in MV-ZPB-infected rabbits,
especially at day 30 postinfection (Fig. 5). The numbers
Table 2
Number of follicles in ovarian sections from infected and uninfected female
rabbits
Groups Tertiary Secondary Primary
Controls 14.8 F 1.7 28.8 F 6.4 32.5 F 5.8
MV-ZPB Day 5 15.3 F 3.3 25.8 F 3.3 33.8 F 7.3
MV-ZPB Day 15 14.5 F 2.4 23.8 F 15.1 39.5 F 20.7
MV-HA Day 15 12 F 3.6 25.8 F 11.3 32.3 F 18.4
MV-ZPB Day 30 8.5 F 4.1* 14.5 F 4.9 29.5 F 9.6
MV-HA Day 30 16.3 F 3.9 20.8 F 4.6 29.8 F 13.9
Notes: the values are mean F SD for four rabbits in each group.
Preovulatory follicles were follicles at a diameter greater than 0.5 mm on a
representative section of 4–6 serial ovarian sections. Primary follicles were
classified as follicles with one layer of granulosa cells. Secondary follicles
were classified as follicles with two or more layers of granulosa cells but
without an antrum. Tertiary follicles were defined as follicles with multiple
layers of granulosa cells and an antrum.
*P < 0.05 against both uninfected and MV-HA infected controls.
Fig. 4. Comparison of preovulatory follicles in ovarian sections. Each
image represents the ovarian section from an individual rabbit in each
group. Control: uninfected control group; MV-HA: MV-HA Day 30 group;
MV-ZPB: MV-ZPB Day 30 group.
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then counted (Table 2). Compared with uninfected and MV-
HA-infected controls, MV-ZPB-infected rabbits had signifi-Fig. 5. Pathological changes in infected rabbit ovaries. A is an ovary from an un
present. B is from the MV-ZPB Day 5 group, showing that normal follicles at diffe
ZPB Day 15 group showing that there were still quite a few normal-looking follicle
D is from the MV-ZPB Day 30 group showing the degenerated follicles (arrows) at
MV-ZPB Day 30 group but with massive accumulation of luteinized cells in the co
from the MV-HA Day 30 group showing that some normal-looking follicles were
secondary follicles. Pr: primary follicles. Lc: luteinized cells.cantly fewer tertiary follicles at 30 days postinfection (Table
2). The number of secondary follicles in this group was also
significantly lower (P < 0.05) than that of the uninfected
control, but it was not different from the corresponding MV-infected control rabbit; many follicles at different developmental stages are
rent developmental stages were also present in the ovary. C is from the MV-
s present in the ovary though some degenerated follicles (arrows) were seen.
the edge of the accumulation of luteinized cells. E is also an ovary from the
rtex, no secondary and tertiary follicles were present. F represents the ovary
present in the ovary. All are 100 magnification. Te: tertiary follicles. Se:
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primary follicles for the MV-HA-infected groups were not
significantly different from those for the uninfected controls
(Table 2). Primordial follicle numbers did not appear to be
affected by the infections although they were not counted. In
addition to the reduction in follicle numbers, degenerated
follicles were often seen in ovaries from both the MV-ZPB-
and MV-HA-infected groups. The degenerate follicles were
characterized by degenerated granulosa cells (dark-stained
nuclei with unclear-shaped cell cluster in the follicles) and
shrunken follicles (Figs. 5C and D). More degenerated
follicles were found in the ovary from both MV-ZPB- and
MV-HA-infected rabbits at 15 days postinfection than 30
days postinfection. However, more degenerated follicles
were seen in the MV-ZPB Day 30 group than the MV-HA
Day 30 group.
Another histological observation in the ovary of myxoma
virus-infected rabbits was the massive accumulation of large
pale-stained cells in the cortex and medulla. This was
especially the case for the MV-ZPB-infected rabbits (Fig.
5E). These cells were described as resembling luteinized
cells in the previous studies for rabbits (Kerr et al., 1999)
and mice (Jackson et al., 1998). Accumulation of these cells
appeared to be associated with follicle degeneration and
loss. Wherever these cells accumulated the follicles degen-
erated (Fig. 5D), and there were no follicles seen in the areas
infiltrated with these cells (Fig. 5E). However, the accumu-
lation of these cells was not found in ovaries from unin-
fected controls. These cells were first seen in the medulla of
ovaries from two rabbits in the MV-ZPB Day 5 group and
were found in greater number and more rabbits in the MV-
ZPB Day 15 group. In this group, they were found in both
the medulla and the cortex of some of the rabbits. Massive
accumulations of luteinized cells in the medulla and cortex
were observed in most of the rabbits from the MV-ZPB Day
30 group (Table 3). Some accumulation of luteinized cells
was also observed in the MV-HA-infected rabbits at both
time points, but was much less than that observed in the
MV-ZPB-infected groups (Table 3).Table 3
Rate and intensity of luteinized cell accumulation in the ovary
Groups a + ++ +++ ++++
Controls 4/4b 0 0 0 0
MV-ZPB Day 5 2/4 2/4 0 0 0
MV-ZPB Day 15 0 0 3/4 1/4 0
MV-ZPB Day 30 0 0 0 1/4 3/4
MV-HA Day 15 0 2/4 0 1/4 1/4
MV-HA Day 30 0 2/4 1/4 1/4 0
a The accumulation of luteinized cells was scored as: , no luteinized cells
in whole section; +, luteinized cells were present in some area of the
medulla; ++, luteinized cells were present in most areas of the medulla but
not in the cortex; +++, luteinized cells were seen in most areas of the
medulla and some areas of the cortex; ++++, luteinized cells were present in
the whole medulla and most areas of the cortex.
b Rabbits with altered ovarian morphology as a proportion of total rabbits in
the group.Discussion
The key results of this study are, firstly, that infection
with MV-ZPB induced a serum antibody response to ZPB
and that this antibody bound to the zona pellucida in the
ovarian follicles of the immunized rabbits. Secondly, this
immunization was associated with a significant decrease in
follicle numbers in immunized rabbits compared to control
rabbits. Thirdly, detectable T cell responses in the ovary
were confined to only a small proportion of immunized
rabbits and the specificity of these T cells is unknown.
Finally, these results demonstrated that presentation of the
self-antigen ZPB by a recombinant myxoma virus was able
to overcome immune tolerance.
However, a previous study (Kerr et al., 1999) showed
that only 3/12 of MV-ZPB-infected female rabbits were
infertile when they were mated at 34 days postinfection.
This suggests that even though follicle numbers were
significantly reduced in the ovaries of immunized animals
and antibody had coated the zona pellucida, which is the
initial sperm binding site on oocytes, this was not sufficient
to block fertility. In the same study, Kerr et al. (1999) also
showed that when MV-ZPB-immunized female rabbits were
boosted with recombinant ZPB protein, the infertility rate
increased to 80% and in some ovaries there was almost
complete follicle loss. This suggests that a high and lasting
antibody response with complete follicle losses could be
important to infertility.
The mechanism of follicle loss is not fully understood. In
mice, ZP-specific CD4+ T cells or pathogenic T cells were
essential in ovarian pathogenesis and follicle losses follow-
ing immunization with a mouse ZPC peptide (Tung and
Teuscher, 1995); (Garza et al., 1998). In rabbits, however, it
was shown that the antibody response could cause follicle
losses, probably through antibody binding to oocytes and
blocking the communication between oocytes and granulosa
cells (Skinner et al., 1984). Significant loss of follicles at the
preovulatory or tertiary stage occurred after MV-ZPB infec-
tion. Some follicle loss and degeneration was also observed
following infection with the control virus MV-HA. This
suggests a simple model to explain both follicle loss and the
way in which self-antigen presentation by myxoma virus
may be overcoming tolerance to self-antigens.
In this model, the attenuated recombinant myxoma virus
would act as a ‘‘danger signal’’ (Gallucci and Matzinger,
2001), inducing an inflammatory response with the produc-
tion of nonspecific antiviral factors such as IL-1h, TNF-a,
IFN-g, and IFN-a/h as well as many other pro-inflamma-
tory factors (Best and Kerr, 2000; Kerr and McFadden,
2002). Some of these factors could induce a toxic environ-
ment in the ovary with subsequent follicle loss (Coulam and
Stern, 1991; Quirk et al., 1998). This occurs via inflamma-
tory factors in serum entering the ovary and does not require
myxoma virus replication in the ovary. In fact, myxoma
virus replicates poorly, if at all in the ovary (Fenner and
Ratcliffe, 1965; Marlier et al., 2000). In this model, the
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tive antigen presentation of both viral antigens and ZPB in
lymph nodes draining the infection site and an adaptive
immune response to the virus and to ZPB.
The inflammatory environment created by the replicat-
ing virus would thus serve to enhance presentation and
recognition of a self-antigen. The increased loss of follicles
in the ovaries from rabbits immunized with MV-ZPB
compared to MV-HA is then largely explained by the
priming of the ovary by this inflammatory response by
both viruses and the binding of antibody to the zona
pellucida in rabbits immunized with MV-ZPB. In this
model, once the virus has been cleared and the inflamma-
tory response has ceased, then normal peripheral tolerance
mechanisms lead to the deletion or inactivation of T cells
to ZPB and the loss of memory B cells. MV-ZPB is
slightly more virulent than MV-HA, leaving a formal
possibility that the differential loss of follicles is entirely
due to the inflammatory response produced by the more
virulent virus.
Kerr et al. (1999) showed that follicle losses were not
observed at 90–100 days postinfection with MV-ZPB,
supporting the view that the viral infection has only a
limited and temporary effect on ovarian follicles. Further-
more, infection of female rabbits with the parent strain of
MV-ZPB (strain Uriarra) had no effect on fertility (Kerr
et al., 1999). In contrast to these results with myxoma
virus, high levels of sustained immunity have been
induced in mice with recombinant mouse poxvirus or
recombinant murine cytomegalovirus expressing the
mouse ZPC antigen (Jackson et al., 1998; Lloyd et al.,
2003). The mouse poxvirus model provides a very good
model for myxoma virus as both are poxviruses which in
the virulent form cause lethal disease in their respective
hosts. At this stage, it is unclear why myxoma virus only
induces a transient autoimmune disease with rapid recov-
ery of the ovary while mouse poxvirus is able to induce
a long-lasting infertility. Both virus, antigen, and host
factors are probably involved and further studies into
basic mechanisms of autoimmunity induced by a recom-
binant myxoma virus in rabbits will be needed before
any development of virally vectored immunocontraception
for rabbits will be practical.Material and methods
Recombinant myxoma virus and ZPB antigen
Recombinant myxoma virus encoding rabbit zona pellu-
cida protein B (MV-ZPB) was as previously described (Kerr
et al., 1999). The ZPB cDNA (RC55 cDNA) was cloned
into the recombinant virus under the control of the poxvirus
P11 later promoter. This is the same site and promoter used
to insert the influenza virus HA in MV-HA (Kerr and
Jackson, 1995). Both the MV-HA and MV-ZPB are highlyattenuated compared with their parent myxoma virus strain
(Uriarra-2-53/1) which is itself an attenuated grade V strain
of myxoma virus.
Recombinant rabbit ZPB protein was expressed in the
rabbit RK13 cell line infected with the vaccinia virus—ZPB
(Kerr et al., 1999). The ZPB protein was then purified by
affinity chromatography using monoclonal antibody
IG7E11 (kindly provided by Nigel French and Hannah
Clarke, CSIRO Wildlife and Ecology, Australia) and used
for ZPB antibody measurement.
Animal, immunization, and sampling
Mature female New Zealand white rabbits (bred at
CSIRO Wildlife and Ecology) were used in the immuniza-
tion experiments, which were approved by Gungahlin
Animal Experimentation Ethics Committee, CSIRO Sus-
tainable Ecosystems. All infected animals were housed
under PC2 containment conditions. For the experimental
time course, 12 female rabbits were intradermally inoculated
with 1  103 pfu of MV-ZPB. Four rabbits were killed at
days 5, 15, and 30 postinfection, respectively. As infected
controls, eight female rabbits at the same age were similarly
infected with 1  106 pfu MV-HA (compared with MV-
ZPB, MV-HA is much less virulent, therefore a higher dose
was chosen). Four rabbits were killed at days 15 and 30
postinfection, respectively. Another group of four normal
rabbits was killed as uninfected controls. When rabbits were
killed, blood was collected for serum and ovaries were
collected for preparing frozen or paraffin-embedded sections
(the left ovaries were frozen and the right ovaries used for
paraffin-embedded sections).
Antibody measurement
ELISA was used to measure IgG antibody titers to ZPB
as described previously (Kerr et al., 1999). Briefly, micro-
plates were coated with purified recombinant rabbit ZPB
protein (2 Ag/well) in carbonate coating buffer. The plates
were then washed and blocked with 3% skim milk/PBS.
Serum samples were serially diluted and added to the wells
for 2-h incubation. After washes, the plates were applied
with antibody conjugate for 1 h and followed by color
reaction and plate reading.
Immunoblotting
Immunoblotting was conducted to confirm the IgG
antibody reaction to ZP protein according to the standard
protocol (Sambrook et al., 1989). The ZP solubilized in 50
mM bicarbonate buffer (pH 8.5) and protein loading buffer
was separated by SDS-PAGE gel and transferred onto
PVDF membranes (NEN Research Products, MA, USA).
The mixed sera from the MV-ZPB Day 15 and Day 30
groups were diluted (1:100) and used as primary antibody.
Anti-rabbit IgG conjugated with HRP (Southern Biotech-
W. Gu et al. / Virology 318 (2004) 516–523522nology Associates, Inc.) was used to detect the antibody
reaction.
Immunofluorescence and histological examination
Preparation of frozen sections and immunofluorescent
staining were as previously described (Gu et al., 2003).
Briefly, frozen sections were prepared and blocked with 3%
skim milk before staining. The sections were incubated with
diluted goat anti-rabbit IgG, or IgM, or IgA sera (Nordic) in
each staining. Antibody binding was then detected using
rabbit anti-goat IgG conjugated with FITC (Nordic). For
rabbit T cell labelling, two monoclonal antibodies, clone
KEN-5 and L11/135 (SeroTec, Australia), were used as
primary antibodies. The secondary antibody was sheep
anti-mouse IgG conjugated with FITC (Silenus). For IgG
antibody specificity test, the mixed serum from MV-ZPB
D15 and D30 groups was diluted (1:100) and used as primary
antibody. Goat anti-rabbit IgG conjugated with FITC (South-
ern Biotechnology Associates, Inc.) was used as secondary
antibody to detect IgG antibody binding. All slides were
examined by confocal microscopy (Bio-Rad, MRC 1000).
For histological examination, the whole ovary was col-
lected and transferred into 4 ml of Bouin’s fixation solution
(0.9% picric acid (w/v); 9% formaldehyde (v/v); 5% acetic
acid (v/v)) for 4 h. The fixation solution was then replaced
by 4 ml 70% alcohol and this was repeated several times in
48 h. The ovaries were paraffin-embedded, sectioned, and
stained with hematoxylin and eosin (H&E).
Data analysis
Antibody titers were transformed into logarithms and
expressed as Log10 titers in the text. Student’s t test (P <
0.05) was used to test the difference between treated and
untreated groups.Acknowledgments
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